Literature DB >> 23118671

Acute intoxication caused by a synthetic cannabinoid in two adolescents.

Travis S Heath1, Zachary Burroughs, A Jill Thompson, Frederick W Tecklenburg.   

Abstract

Illicit drug use continues to be a common problem among pediatric patients. Daily marijuana use among high school seniors is currently at a 30-year high. Marijuana use in adults has rarely been associated with cardiovascular adverse effects, including hypertension, tachycardia, arrhythmia, and myocardial infarction. Recently, abuse of synthetic cannabinoids, such as the incense "K2" or "Spice," has been increasingly reported in the lay press and medical literature. Overdose and chronic use of these substances may cause adverse effects including altered mental status, tachycardia, and loss of consciousness. Overdoses in adult patients have been described; however, limited reports in the pediatric population have been documented. A recent case series describes myocardial infarctions in pediatric patients, associated with synthetic cannabinoid use. In this report, we describe two adolescent patients admitted after they inhaled "K2," resulting in loss of consciousness, tachycardia, and diffuse pain.

Entities:  

Keywords:  K2; Spice; synthetic cannabinoids

Year:  2012        PMID: 23118671      PMCID: PMC3470439          DOI: 10.5863/1551-6776-17.2.177

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  21 in total

Review 1.  Cannabis use and cerebrovascular disease.

Authors:  Michael Moussouttas
Journal:  Neurologist       Date:  2004-01       Impact factor: 1.398

2.  'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

Authors:  Volker Auwärter; Sebastian Dresen; Wolfgang Weinmann; Michael Müller; Michael Pütz; Nerea Ferreirós
Journal:  J Mass Spectrom       Date:  2009-05       Impact factor: 1.982

3.  The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.

Authors:  Helge Müller; Wolfgang Sperling; Martin Köhrmann; Hagen B Huttner; Johannes Kornhuber; Juan-Manuel Maler
Journal:  Schizophr Res       Date:  2010-01-08       Impact factor: 4.939

4.  Triggering myocardial infarction by marijuana.

Authors:  M A Mittleman; R A Lewis; M Maclure; J B Sherwood; J E Muller
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

Review 5.  The "new" marijuana.

Authors:  Daina L Wells; Carol A Ott
Journal:  Ann Pharmacother       Date:  2011-02-15       Impact factor: 3.154

6.  Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.

Authors:  Wen Jiang; Yun Zhang; Lan Xiao; Jamie Van Cleemput; Shao-Ping Ji; Guang Bai; Xia Zhang
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

Review 7.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

8.  Regional brain abnormalities associated with long-term heavy cannabis use.

Authors:  Murat Yücel; Nadia Solowij; Colleen Respondek; Sarah Whittle; Alex Fornito; Christos Pantelis; Dan I Lubman
Journal:  Arch Gen Psychiatry       Date:  2008-06

Review 9.  Adverse effects of cannabis on health: an update of the literature since 1996.

Authors:  Harold Kalant
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-08       Impact factor: 5.067

10.  Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".

Authors:  Ulrich S Zimmermann; Patricia R Winkelmann; Max Pilhatsch; Josef A Nees; Rainer Spanagel; Katja Schulz
Journal:  Dtsch Arztebl Int       Date:  2009-07-03       Impact factor: 5.594

View more
  19 in total

1.  K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report.

Authors:  Rita G McKeever; David Vearrier; Dorian Jacobs; Gregory LaSala; Jolene Okaneku; Michael I Greenberg
Journal:  J Med Toxicol       Date:  2015-03

Review 2.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 3.  Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.

Authors:  Vikas Khullar; Ankur Jain; Maryam Sattari
Journal:  J Gen Intern Med       Date:  2014-02-20       Impact factor: 5.128

4.  Synthetic cannabinoid, JWH-030, induces QT prolongation through hERG channel inhibition.

Authors:  Jaesuk Yun; Kyung Sik Yoon; Tac-Hyung Lee; Hyunjin Lee; Sun Mi Gu; Yun Jeong Song; Hye Jin Cha; Kyoung Moon Han; Hyewon Seo; Jisoon Shin; Hye-Kyung Park; Hyung Soo Kim; Young-Hoon Kim
Journal:  Toxicol Res (Camb)       Date:  2016-09-07       Impact factor: 3.524

5.  Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Authors:  Francois R Lamy; Raminta Daniulaityte; Ramzi W Nahhas; Monica J Barratt; Alan G Smith; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2017-06-01

Review 6.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

7.  Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.

Authors:  Adebisi I Obafemi; Kurt Kleinschmidt; Collin Goto; Drew Fout
Journal:  J Med Toxicol       Date:  2015-12

8.  Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Timothy W Lefever; Julie A Marusich; Richard C Kevin; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-03-16       Impact factor: 4.030

9.  The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse.

Authors:  Samuel D Banister; Shane M Wilkinson; Mitchell Longworth; Jordyn Stuart; Nadine Apetz; Katrina English; Lance Brooker; Catrin Goebel; David E Hibbs; Michelle Glass; Mark Connor; Iain S McGregor; Michael Kassiou
Journal:  ACS Chem Neurosci       Date:  2013-04-17       Impact factor: 4.418

Review 10.  Modulating the endocannabinoid system in human health and disease--successes and failures.

Authors:  Pál Pacher; George Kunos
Journal:  FEBS J       Date:  2013-04-22       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.